Quantum Farma and FarmaUSA launch cannabinoids focusing on cancer and chronic pain treatment in Brazil : vimarsana.com

Quantum Farma and FarmaUSA launch cannabinoids focusing on cancer and chronic pain treatment in Brazil


Quantum Farma Logo
Farma USA logo
References in the Medicinal Cannabis segment, the companies come together to offer products that raise the effectiveness of palliative care to new levels.
SAO PAULO, BRAZIL, July 30, 2021 /EINPresswire.com/ -- Quantum Farma, a UK based company that provides high grade cannabinoid containing products and services to patients in Latin America and other regions, in a strategic partnership with FarmaUSA, a company specializing in the manufacture and import of medicines and a pioneer in Medicinal Cannabinoids in Brazil, promise a milestone in the Brazil's pharmacy market.
Together, on July 28, they launched two innovative drugs at an exclusive online event for more than 600 doctors: Medrosan Forte, which has a high concentration of THC, and Medrosan Extra, which includes cannabigerol, a new type of cannabinoid whose prescription is growing worldwide.

Related Keywords

United States , United Kingdom , Switzerland , Brazil , America , Swiss , Karans Madan , Medropharm Gmb , Medrosan Forte , Swiss Medicines Agency , Quantum Farma , Medicinal Cannabis , Latin America , Medicinal Cannabinoids , Medrosan Extra , Full Spectrum , Technical Director , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , சுவிட்சர்லாந்து , பிரேசில் , அமெரிக்கா , சுவிஸ் , மருத்துவ கஞ்சா , லத்தீன் அமெரிக்கா , முழு ஸ்பெக்ட்ரம் , தொழில்நுட்ப இயக்குனர் ,

© 2024 Vimarsana